ZimVie Inc

ZimVie — Investor Presentation (February 2024)

10 slides from ZimVie's investor presentation, Feb 28, 2024

  1. Slide 1: Corporate Overview February 2024

    Corporate Overview February 2024 Exhibit 99.2

  2. Slide 2: Forward-looking statements and Non-GAAP measures

    Forward-looking statements and Non-GAAP measures Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 This presentation contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-lo

  3. Slide 3: ZimVie: A global dental leader

    ZimVie: A global dental leader Powerful, market-leading portfolio of premium implants, biomaterials, and digital dentistry with exposure to MSD/HSD growth end-markets Well positioned to accelerate growth within large, attractive, and underserved markets through differentiated technologies Opportunit

  4. Slide 4: Addressing a significant, unmet need for tooth replacement

    Addressing a significant, unmet need for tooth replacement 8 Million An estimated 8 million US patients seek treatment for tooth loss annually 25% Only 25% receive tooth replacement Leading player in the following attractive dental segments 2021 Market Opportunity 2021-2026E(1) CAGR Dental implants

  5. Slide 5: Diversified dental portfolio addresses end-to-end patient needs

    Diversified dental portfolio addresses end-to-end patient needs Increase Penetration of Implants through Continued Innovation and Commercial Execution Implant Growth: Innovation & Execution Leverage Leadership Position to Drive Implant Conversion Biomaterials Pull-Through Scale ZimVie Presence Acros

  6. Slide 6: Delivering fully integrated and end-to-end implant-based tooth replacement solutions

    Delivering fully integrated and end-to-end implant-based tooth replacement solutions Driving Premium Implant Growth Through Innovation Leveraging Biomaterials Leadership Position Digital Dentistry Driving Implant Adoption Comprehensive line of premium implant systems, meeting the varying needs of or

  7. Slide 7: Financial profile and outlook

    Financial profile and outlook Net Sales Adjusted EBITDA Margin FY 2023* Year 1 Post-Close** Transition year in 2024 to build a strong foundation for long-term performance $457.2M 11.1%(1) $455M+ 15%+(2) Net Debt ~$421.0M(3) Drivers of financial progress Sales growth above market Operational simplifi

  8. Slide 8: Long-term outlook

    Long-term outlook Leverage innovation to grow above market Drive progress across the business to create long-term shareholder value Achieve 20%+ Adj EBITDA margin(1) 80%+ FCF Conversion(1)(2) Achieve 2x operating leverage Innovation pipeline poised to accelerate growth in faster growing end markets

  9. Slide 9: Appendix

    Dp Appendix Confidential 2 ZimVie

  10. Slide 10: Reconciliation of Adjusted EBITDA

    Reconciliation of Adjusted EBITDA (in thousands) (1) In April 2023, we initiated restructuring activities to better position our organization for future success based on the current business environment, and in July 2023, we took additional actions. The expenses incurred under this plan were primari

ZimVie — Investor Presentation (February 2024) on 6ix